dronabinol has been researched along with Brain Infarction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cooper, JJ; Grant, J | 1 |
Gai, N; Leker, RR; Mechoulam, R; Ovadia, H | 1 |
Abe, K; Egashira, N; Fujiwara, M; Hasebe, N; Hayakawa, K; Ikeda, T; Inui, K; Iwasaki, K; Mishima, K; Takamatsu, F; Yasuda, H | 1 |
3 other study(ies) available for dronabinol and Brain Infarction
Article | Year |
---|---|
Refractory OCD Due to Thalamic Infarct With Response to Dronabinol.
Topics: Brain Infarction; Cognitive Behavioral Therapy; Dronabinol; Humans; Male; Obsessive-Compulsive Disorder; Psychotropic Drugs; Thalamus; Treatment Outcome; Young Adult | 2017 |
Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210.
Topics: Animals; Blood Pressure; Body Temperature; Brain Infarction; Brain Ischemia; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Heart Rate; Hypothermia, Induced; Motor Activity; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rewarming; Treatment Outcome | 2003 |
Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism.
Topics: Analysis of Variance; Animals; Body Temperature; Brain Infarction; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Fever; Infarction, Middle Cerebral Artery; Male; Mice; Neuroprotective Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Tetrazolium Salts; Time Factors | 2004 |